Neopterin and the anti-Mullerian hormone's role in Unexplained Recurrent Pregnancy Loss
Main Article Content
Abstract
Material’s and Methods: A case control study was done in the Department of Obstetrics and Gynecology Salahdeen general hospital in Tikrit city from first January to thirty of August 2020. One hundred patient enrolled in the study. Study contains two groups:1- Group A as cases. 2- Group B as control group. The data collection done through:1-Designed closed and open-ended questionnaire, 2- Laboratory investigations of : Serum Neopterin and Anti-Mullerian hormone levels using enzyme-linked immunosorbent assay.
Results: Mean Neopterin level was significantly higher among cases (24.3±10.7)nml/l than control group (2.9±1.1) nml/l. Mean Neopterin level increased with increasing abortion number. It was significantly higher among those with ≥5 abortions (30.02±10.04) nml/l than those with (3-4) and 2 abortions (28.7±15.29) nml/l and (20.1±0.03) nml/l. The mean Neopterin level increased with increasing age among cases and controls. Among cases was (28.7±12.03) nmol/L among those aged (31- 35) year, which was higher than those aged (18-25), and those aged (26-35) years Mean Anti-Mullerian hormone level was significantly lower among cases (0.8±0.6) ng/ml than control group (5.01±2.7) ng/ml. Mean Anti-Mullerian hormone level was significantly higher among those with 2 abortions (1.06±0.7) ng/ml than those with (3-4) and 5 abortions (0.6±0.56) ng/ml and (0.97±0.4) ng/ml respectively. Among case the mean AMH level was lower among those aged (31-35) years (0.5±0.31) ng/ml than those aged (26-30), and (18-25) years (0.8±0.7) ng/ml, (0.97±0.7) ng/ml, respectively
Conclusions: A statistically significant high Mean Neopterin level among cases and its increased mean Neopterin level with increasing abortion number. A statistically significant low levels of mean Anti-Mullerian hormone level among cases, more reduction in its level with increasing abortion. This pioneer study in Iraq, determined the significant association between the unexplained recurrent pregnancy loss with the increased levels of Neopterin and its effect on Anti-Mullerian hormone that lead to recurrent pregnancy loss.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Priya PK, Mishra VV, Roy P, Patel H. A study on balanced chromosomal translocations in couples with recurrent pregnancy loss. Journal of human reproductive sciences 2018; 11(4):337.
II. Abdulrahman I, Jawad A, Amin N. Recurrent pregnancy loss at gynecology and obstetrical hospital in Duhok Province. International Journal of Research in Medical Sciences August 2020; 8(9): DO - 10.18203/2320-6012.ijrms20203511
III. Kolte A, Bernardi L, Christiansen O, Quenby S, Farquharson R, Goddijn M, et al. Terminology for pregnancy loss prior to viability: a consensus statement from the ESHRE early pregnancy special interest group. Human Reproduction 2015; 30(3):495-8.
IV. Medicine PCotASfR. Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertility and sterility 2012; 98(5):1103-11.
V. Rull K, Nagirnaja L, Laan M. Genetics of recurrent miscarriage: challenges, current knowledge, future directions. Frontiers in genetics 2012; 3: 34.
VI. Barišić A, Pereza N, Hodžić A, Krpina MG, Ostojić S, Peterlin B. Genetic variation in the maternal vitamin D receptor FokI gene as a risk factor for recurrent pregnancy loss. The Journal of Maternal-Fetal & Neonatal Medicine. 2019:1-6.
VII. Idowu D, Merrion K, Wemmer N, Mash JG, Pettersen B, Kijacic D, et al. Pregnancy outcomes following 24-chromosome preimplantation genetic diagnosis in couples with balanced reciprocal or Robertsonian translocations. Fertility and sterility. 2015; 103(4):1037-42.
VIII. Michalak Ł, Bulska M, Strząbała K, Szcześniak P. Neopterin as a marker of cellular immunological response. Postepy higieny i medycyny doswiadczalnej (Online). 2017 Aug 1;71(1):727-36.
IX. Sencan H, Keskin N, Khatib G. The role of neopterin and anti-Mullerian hormone in unexplained recurrent pregnancy loss–a case-control study. Journal of Obstetrics and Gynaecology. 2019; 39(7):996-9.
X. Lindhardt Johansen M, Hagen CP, Johannsen TH, Main KM, Picard J-Y, Jørgensen A, et al. Anti-müllerian hormone and its clinical use in pediatrics with
XI. special emphasis on disorders of sex development. Int J Endocrinol 2013; 2013:198698-.
XII. Rey RA, Grinspon RP. Normal male sexual differentiation and aetiology of disorders of sex development. Best Practice & Research Clinical Endocrinology & Metabolism. 2011;25(2):221-38.
XIII. Rifat AG, Salman YJ. Anti-Mullerian Hormone in Women with Recurrent Miscarriage. The Medical Journal of Tikrit University. 2017; 23(1): 33-43.
XIV. Oğlak SC, Aydın MF. Are neutrophil to lymphocyte ratio and platelet to lymphocyte ratio clinically useful for the prediction of early pregnancy loss?. Ginekologia Polska. 2020; 91(9):524-7.
XV. Siristatidis C, Christoforaki V, Zafeiriou Z, Mastorakos G, Vrantza T, Daskalakis G. First trimester neutrophil-to-lymphocyte ratio (NLR) and pregnancy outcomes in medically assisted reproduction (MAR): a case control study.
XVI. Gynecological Endocrinology 2019; 35(5):434-8.
XVII. Chaithra PT, Kavitha P, Sreenivasa G, Malini SS. Recurrent Pregnancy Loss– Is It Advanced Age or Advanced Maternal Mother’s Age of Young Women a Major Contributing Factor. IOSR-JDMS. 2015;14(4):81-7.
XVIII. Sencan H, Keskin N, Khatib G. The role of neopterin and anti-Mullerian hormone in unexplained recurrent pregnancy loss–a case-control study. Journal of Obstetrics and Gynaecology 2019 Oct 3;39(7):996-9.
XIX. Ünüvar S, Tanrıverdi Z. Neopterin And Recurrent Spontaneous Abortı̇on (Rsa): The Effect Of Cellular Immune System Activation On Subsequent Pregnancy. InCBU International Conference Proceedings 2017; 5: 1028-1031.
XX. Kuon RJ, Schaumann J, Goeggl T, Strowitzki T, Sadeghi M, Opelz G, Daniel V, Toth B. Patients with idiopathic recurrent miscarriage show higher levels of
XXI. DR+ activated T-cells that are less responsive to mitogens. Journal of reproductive immunology 2015;112: 82-7.
XXII. Siwetz M, Blaschitz A, El-Heliebi A, Hiden U, Desoye G, Huppertz B, Gauster
XXIII. M. TNF-α alters the inflammatory secretion profile of human first trimester placenta. Laboratory investigation. 2016; 96(4):428-38
XXIV. No RG. The investigation and treatment of couples with recurrent first-trimester and second-trimester miscarriage. RCOG: London, UK. 2011: 75-81.
XXV. Pils S, Promberger R, Springer S, Joura E, Ott J Decreased Ovarian Reserve Predicts Inexplicability of Recurrent Miscarriage? A Retrospective Analysis. PLoS ONE (2016); 11(9): e0161606. https://doi.org/10.1371/journal.pone.0161606]
XXVI. Choi TY, Lee HM, Park WK, Jeong SY, Moon HS. Spontaneous abortion and recurrent miscarriage: a comparison of cytogenetic diagnosis in 250 cases. Obstet Gynecol Sci (2014); 57(6):518–525
XXVII. Revelli A, Biasoni V, Gennarelli G, Canosa S, Dalmasso P, Benedetto C. IVF results in patients with very low serum AMH are significantly affected by chronological age. Journal of assisted reproduction and genetics 2016; 33(5):603-9.
XXVIII. Kedem A, Haas J, Geva LL, Yerushalmi G, Gilboa Y, Kanety H.. Ongoing pregnancy rates in women with low and extremely low AMH levels. A multivariate analysis of 769 cycles. PLoS ONE. 2013; 8:e81629
XXIX. Granot I, Gnainsky Y, Dekel N. Endometrial inflammation and effect on implantation improvement and pregnancy outcome. mReproduction. 2012; 144:661–668
XXX. Christoforaki V, Zafeiriou Z, Daskalakis G, Katasos T, Siristatidis C. First trimester neutrophil to lymphocyte ratio (NLR) and pregnancy outcome. Journal of Obstetrics and Gynaecology 2020; 40(1):59-64.
XXXI. Templeton AJ, Ace O, McNamara MG, Al-Mubarak M, Vera-Badillo FE,
XXXII. Hermanns T, Šeruga B, Ocana A, Tannock IF, Amir E. Prognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review and meta-analysis. Cancer Epidemiology and Prevention Biomarkers 2014; 23(7):1204-12.
XXXIII. Krenn-Pilko S, Langsenlehner U, Thurner EM, Stojakovic T, Pichler M, Gerger A, Kapp KS, Langsenlehner T. The elevated preoperative platelet-to- lymphocyte ratio predicts poor prognosis in breast cancer patients. British journal of cancer 2014; 110(10): 2524-30.
XXXIV. Al-Aghbary AA, Almorish MA, Jaffar DW, Al-Kahiry WM. Platelet indices in evaluation of patients with recurrent pregnancy loss. Asian Pacific Journal of Reproduction 2018; 7(1):15
XXXV. Meena R, Meena ML, Meena P, Meena R. Association of increased platelet distribution width and red cell distribution width with recurrent pregnancy loss. Int J Reprod Contracept Obstet Gynecol 2017; 6(3): 1083- 1086.
XXXVI. Avcıoğlu SN, Altınkaya SÖ, Küçü M, Sezer SD, Yüksel H. The association between platelet indices and clinical parameters in recurrent pregnancy loss. Gynecol Obstet Reprod Med 2014; 20(20): 146-149.
XXXVII. Dundar O, Pektas MK, Bodur S, Bakır LV, Cetin A. Recurrent pregnancy loss is associated with increased red cell distribution width and platelet
XXXVIII. distribution width. J Obstet Gynaecol Res 2015; 41(4): 551-558.
XXXIX. American College of Obstetricians and Gynecologists. Practice bulletin no. 166: thrombocytopenia in pregnancy. Obstetrics and gynecology. 2016; 128(3):e43-53